Patent ID: 7438935
Filing Date: 2008-10-21
Classification: A61K,A61P

Abstract:
1. A Pharmaceutical composition comprising: 5.0%-70.0% by weight Radix Salviae Miltiorrhizae extract; 10.0%-85.0% by weight Radix Notoginseng extract; 5.0%-70.0% by weight Radix Astragali extract; and 1.0%-15.0% by weight Borneol or oil of Lignum Dalbergiae Odoriferae, wherein said Radix Salviae Miltiorrhizae extract comprises 45% -70% by weight salvianolic acid B, 2% -10% by weight salvianolic acid E, 4% -20% by weight rosmarinic acid, 1%-10% by weight lithospermic acid, and more than 70% by weight salvinolic acids; said Radix Notoginseng extract comprises 2% -10% by weight notoginsenoside R1, 2% -6% by weight ginsenoside Re, 15% -40% by weight ginsenoside Rg1, 15%-40% by weight ginsenoside Rb1, 5% -12% by weight ginsenoside Rd, and more than 70% by weight radix notoginseng saponins; and said Radix Astragali extract comprises 5% -15% by weight astragaloside I and more than 70% by weight Radix Astragali saponins.